Health authorities across the country have recently uncovered numerous cases of counterfeit drugs, drugs of unknown origin, and functional foods containing banned substances at pharmacies.

If you take OTC proton pump inhibitors (PPIs), you could be among the uncounted. Familiar brands include Prilosec (omeprazole), Nexium (esomeprazole), and Prevacid (lansoprazole), among others. They ...

Esomeprazole oral capsule is a prescription drug that decreases the amount of acid the stomach makes. It can be used to treat GERD, esophagitis, and other conditions, and to prevent stomach ulcers ...

Medically reviewed by Femi Aremu, PharmD Proton pump inhibitors (PPIs) are a class of medications used to treat conditions involving excess stomach acid, such as gastroesophageal reflux disorder (GERD ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

Long-term use of proton pump inhibitor drugs have been linked to kidney problems and cancer.

Glenmark has received The Food & Drug Administration’s permission for esomeprazole magnesium delayed-release capsules, 20 mg (OTC), which is the generic of Haleon’s Nexium 24 HR Delayed ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for esomeprazole magnesium delayed-release capsules USP, 20 mg (OTC), determined by ...

Glenmark’s unit gets USFDA for Esomeprazole Magnesium delayed-release capsule The capsule will be distributed in the US by Glenmark Therapeutics Inc., USA. It is bioequivalent to Nexium 2 24 HR ...

NEXIUM Hp7 is a combination pack which contains three different medicines with active ingredients esomeprazole, amoxicillin trihydrate and clarithromycin. When taken together in the right doses ...

Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release capsules Esomeprazole Magnesium capsules are indicated for short-term treatment of heartburn and other symptoms ...

Granules India receives US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules, a generic version of AstraZeneca's Nexium. The annual US market for the drug is $168M, and Granules now ...